Rhumbline Advisers KINIKSA PHARMACEUTICALS INT Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Number of Shares
59,864
Previous 56,066
6.77%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%